TopFunds

Insulet Corporation

NASDAQ: PODD

Stock price

164.06 USD

(+Infinity%) NaN day

Health Care EquipmentMedical - Devices

Financial Performance

Share

5Y price score: (53)

Help

The price score is a basic measure of the stock's performance against the S&P 500 Index over a five-year period.

A score of 100 indicates that the stock did as well as the S&P 500 Index.

A score below 100 means the stock underperformed the index, while a score above 100 means it outperformed the S&P 500.

10Y return: 394%

DATE RANGE:

US$ Per
Share

    Time scale:

    By default your notes are visible only to you.

    138.7

    52-week range

    354.8

    164.06

    Your model inputs

    Required return / cost of capital
    %
    FCFF terminal growth rate
    %

    Your fair value & Margin of safety

    To calculate fair value based on cost of capital and terminal growth assumptions above, please select free cash flow forecast.

    Forecast:

    Valuation

    Free Cash Flow Yield

    Help
    FCF Yield TTM = Trailing Twelve Months free cash flow per share / current market price per shareLearn more

    3.6 %

    Dividend Yield TTM

    -

    Market cap $

    $ 11,364

    Price / Earnings TTM

    Help
    P/E TTM = current market price per share / Trailing Twelve Months diluted earnings per shareLearn more

    38.2

    Price / Book TTM

    8.8

    PEG TTM

    Help
    Price/Earnings-to-Growth ratio = P/E TTM divided by most recent annual diluted earnings per share growth rateLearn more

    (1)

    Earnings growth and return

    LTM

    5YR

    10YR

    Total return (price & dividends)

    (42.1) %

    (38.9) %

    394 %

    Free cash flow per share growth

    27.1 %

    520 %

    1,388.3 %

    Earnings per share growth

    (39.8) %

    3,380 %

    369.8 %

    Founded: 2,000

    Employees: 5,400

    Business Summary:Insulet Corporation specializes in the creation, production, and distribution of advanced insulin management systems for individuals living with insulin-dependent diabetes. At the core of their offerings is the Omnipod System, an innovative solution featuring a unique, self-adhesive, and disposable Omnipod device. This tubeless unit can be directly applied to the body for a duration of up to three days, and it operates in conjunction with a wireless handheld personal diabetes manager. The company's products reach customers predominantly through independent distributors and pharmaceutical channels, though direct sales also occur. Geographically, Insulet serves markets spanning the United States, Canada, Europe, the Middle East, and Australia. Established in 2000, the corporation's headquarters are located in Acton, Massachusetts.

    Fair Value Reference Estimate

    Latest Earnings Call Takeaways

    Annual Reports, Presentations And IR Contacts

    Go to the website
    Annual report links (10K)
    2025202420232022202120202019201820172016

    Insulet Corporation — Financial Overview, Stock Price, Market Cap

    Insulet Corporation is a company. Founded in 2000. As of July 20, 2026, the company's market capitalization is $11363562416 with a current stock price of $164.06.